UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
December 22, 2008
Accession Number:
0000950123-08-018031
Submission Type:
POS AM
CIK:
0001006281
Company Name:
Protalix BioTherapeutics, Inc.
File Number:
333-144801